To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in groups 4, 5, 6, and 7, as well as other rapidly emerging viruses that…
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $618,500
Award facts
- Contract value 81% obligated
-
- $618,500.00 Current, with exercised options
- $767,181.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $618,500 |
About this award
This firm fixed price delivery order, valued at $767,181, was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Utah State University, doing business as USU, to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in Groups 4 through 7 as well as other rapidly emerging viruses. The contract was issued against the In Vitro Assessments of Antimicrobial Activity master IDIQ vehicle to provide in vitro testing services in support of NIAID's broader antimicrobial research efforts. Performance will take place in Logan, Utah over a one year period concluding in September 2021. No subcontractors or set aside designations were identified.
Description
To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in groups 4, 5, 6, and 7, as well as other rapidly emerging viruses that utilize the same assay methodology.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 17, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $618,500 on 75N93020F00002. Its potential value, with all options, is $767,181.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award